Mice expressing GFP and CreER in osteochondro progenitor cells in the periosteum

被引:147
作者
Kawanami, Aya [1 ]
Matsushita, Takehiko [1 ]
Chan, Yuk Yu [1 ]
Murakami, Shunichi [1 ,2 ]
机构
[1] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
Periosteum; Perichondrium; Osteogenesis; Chondrogenesis; GFP; CreER; Tamoxifen; Osteochondro progenitor; Fracture healing; IDENTIFICATION; RECOMBINASE; ENHANCER; PATHWAY;
D O I
10.1016/j.bbrc.2009.06.059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We generated Prx1CreER-GFP transgenic mice that express tamoxifen-inducible Cre recombinase and GFP under the control of a 2.4 kb Prx1 promoter. The transgene is expressed in osteochondro progenitor cells in the developing limb buds and in a subpopulation of periosteal cells that is closely associated with the cortical bone. GFP-expressing cells isolated from the diaphyses of long bones by cell sorting express Multiple markers of periosteal cells, including Prx1, Fgf18, Tenascin-W, Periostin, and Thrombospondin 2. In addition, these cells undergo chondrogenic and osteogenic differentiation in Culture upon induction. Cell fate analysis using the Rosa26 LacZ reporter indicated that transgene-expressing cells give rise to some of the chondrocytes and osteoblasts in the fracture callus. Collectively, these observations Strongly Suggest that the transgene-expressing cells are osteochondro progenitor cells in the periosteum. The established Prx1CreER-GFP mice would offer novel approaches for analyzing the functions of periosteal cells in vitro and in vivo. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:477 / 482
页数:6
相关论文
共 12 条
  • [1] The transcrintion factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6
    Akiyama, H
    Chaboissier, MC
    Martin, JF
    Schedl, A
    de Crombrugghe, B
    [J]. GENES & DEVELOPMENT, 2002, 16 (21) : 2813 - 2828
  • [2] Identification of unique molecular subdomains in the perichondrium and periosteum and their role in regulating gene expression in the underlying chondrocytes
    Bandyopadhyay, Amitabha
    Kubilus, James K.
    Crochiere, Marsha L.
    Linsenmayer, Thomas F.
    Tabin, Clifford J.
    [J]. DEVELOPMENTAL BIOLOGY, 2008, 321 (01) : 162 - 174
  • [3] BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115
  • [4] Colnot C, 2009, J BONE MINER RES, V24, P274, DOI [10.1359/jbmr.081003, 10.1359/JBMR.081003]
  • [5] Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains
    Feil, R
    Wagner, J
    Metzger, D
    Chambon, P
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (03) : 752 - 757
  • [6] Expression of Cre recombinase in the developing mouse limb bud driven by a Prxl enhancer
    Logan, M
    Martin, JF
    Nagy, A
    Lobe, C
    Olson, EN
    Tabin, CJ
    [J]. GENESIS, 2002, 33 (02) : 77 - 80
  • [7] Martin JF, 2000, GENESIS, V26, P225, DOI 10.1002/(SICI)1526-968X(200004)26:4<225::AID-GENE10>3.3.CO
  • [8] 2-6
  • [9] FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway
    Matsushita, Takehiko
    Wilcox, William R.
    Chan, Yuk Yu
    Kawanami, Aya
    Bukulmez, Huelya
    Balmes, Gener
    Krejci, Pavel
    Mekikian, Pertchoui B.
    Otani, Kazuyuki
    Yamaura, Isakichi
    Warman, Matthew L.
    Givol, David
    Murakami, Shunichi
    [J]. HUMAN MOLECULAR GENETICS, 2009, 18 (02) : 227 - 240
  • [10] NAKAHARA H, 1990, CLIN ORTHOP RELAT R, P223